Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest Expense - OthersInterest ExpensesInterest Income - Debt SecuritiesInterest Income - DepositsInterest Income - NetInterest Income - TotalInterest income - InvestmentsInterest income - LoansInvestment Banking IncomeInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesOther interest incomeProfit After TaxProvisionsResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

First Keystone (FKYS) Research & Development (2023 - 2025)

First Keystone (FKYS) has 3 years of Research & Development data on record, last reported at $366000.0 in Q3 2025.

  • For Q3 2025, Research & Development rose 57.76% year-over-year to $366000.0; the TTM value through Sep 2025 reached $1.4 million, up 62.22%, while the annual FY2024 figure was $1.0 million, 21.63% down from the prior year.
  • Research & Development reached $366000.0 in Q3 2025 per FKYS's latest filing, down from $385000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $544000.0 in Q3 2023 and bottomed at $91000.0 in Q4 2023.
  • Average Research & Development over 3 years is $312181.8, with a median of $312000.0 recorded in 2023.
  • The widest YoY moves for Research & Development: up 192.31% in 2024, down 57.35% in 2024.
  • A 3-year view of Research & Development shows it stood at $91000.0 in 2023, then soared by 192.31% to $266000.0 in 2024, then soared by 37.59% to $366000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $366000.0 in Q3 2025, $385000.0 in Q2 2025, and $357000.0 in Q1 2025.